Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin‐10 or antibodies to interleukin‐12
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
There is now increasing evidence that hyperresponsiveness towards intestinal flora is a crucial event in the pathogenesis of inflammatory bowel disease (IBD). In support of this hypothesis, we recently described in humans that tolerance exists towards indigenous intestinal flora but is broken in active IBD lesions. In the present study, we have attempted to transfer this model into mice from different genetic backgrounds (BALB/c, SJL/J, C3H/HeJ). We found that mononuclear cells from spleen, small bowel and large bowel of mice do not proliferate, i.e. are tolerant when exposed to bacterial sonicates derived from autologous intestine (BsA) but do proliferate, i.e. are immune when exposed to bacterial sonicates derived from the heterologous intestine of syngenic littermates (BsH). Furthermore, we demonstrate that both local and systemic tolerance to BsA is broken in a murine model of chronic intestinal inflammation induced by the hapten reagent 2,4,6‐trinitrobenzene sulfonic acid (TNBS), which mimics several important characteristics of Crohn's disease. Tolerance to BsA was restored and TNBS‐induced colitis was abrogated in mice systemically treated with interleukin (IL)‐10 or antibodies to IL‐12. Treatment specifically restored tolerance to BsA, but did not suppress proliferation to BsH. In summary, we here report a new mouse model for the study of immunity and tolerance towards bacterial products. Our data suggest that tolerance to BsA is an important protective mechanism and that restoration of tolerance to resident intestinal flora by IL‐10 and antibodies to IL‐12 may be of potential therapeutic utility in patients with inflammatory bowel disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E., & Strober, W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,335
Self-citationPowrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146
Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J.-P., & Taurog, J. D. (1990) · Cell · doi:10.1016/0092-8674(90)90512-d · Cited by 1,005
Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K., & BÜSchenfelde, K.-H. M. Z. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03836.x · Cited by 940
Self-citationInterleukin-12 and its role in the generation of TH1 cells
Trinchieri, G. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90230-i · Cited by 845
Intestinal flora in health and disease
Simon, G. L., & Gorbach, S. L. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90606-1 · Cited by 822
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
Rutgeerts, P., Peeters, M., Hiele, M., Vantrappen, G., Pennincx, F., Aerts, R., Kerremans, R., & Goboes, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)90663-a · Cited by 759
Cited by
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
Self-citationInterleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Tlaskalová-Hogenová, H., Štěpánková, R., Hudcovic, T., Tučková, L., Cukrowska, B., Lodinová-Žádnı́ková, R., Kozáková, H., Rossmann, P., Bártová, J., Sokol, D., et al. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.02.005 · Cited by 755
War and peace at mucosal surfaces
Sansonetti, P. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1499 · Cited by 679
Importance of disrupted intestinal barrier in inflammatory bowel diseases
Salim, S. Y., & Söderholm, J. D. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21403 · Cited by 602
IL-23 plays a key role in Helicobacter hepaticus –induced T cell–dependent colitis
Kullberg, M. C., Jankovic, D., Feng, C. G., Hue, S., Gorelick, P. L., McKenzie, B. S., Cua, D. J., Powrie, F., Cheever, A. W., Maloy, K. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061082 · Cited by 590
The anatomical basis of intestinal immunity
Mowat, A. M., & Viney, J. L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00966.x · Cited by 493
Cytokines in Inflammatory Bowel Disease
Rogler, G., & Andus, T. (1998) · World Journal of Surgery · doi:10.1007/s002689900401 · Cited by 484
Säemann, M. D., Böhmig, G. A., Österreicher, C. H., Burtscher, H., Parolini, O., Diakos, C., Stöckl, J., Hörl, W. H., & Zlabinger, G. J. (2000) · The FASEB Journal · doi:10.1096/fj.00-0359fje · Cited by 482
Haller, D., Bode, C., Hammes, W. P., Pfeifer, A. M. A., Schiffrin, E. J., & Blum, S. (2000) · Gut · doi:10.1136/gut.47.1.79 · Cited by 466
“This may occur in the newborn intestine when sterile mucosal sites become exposed to mainly non-pathogenic commensal bacteria. However, this also supports the hypothesis that the enteric microflora maintains a chronic and immunologically balanced intestinal inflammatory response.”
ResultLanders, C. J., Cohavy, O., Misra, R., Yang, H., Lin, Y., Braun, J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.35379 · Cited by 440
Vaccination Strategies for Mucosal Immune Responses
Ogra, P. L., Faden, H., & Welliver, R. C. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.430-445.2001 · Cited by 390
Cong, Y., Brandwein, S. L., McCabe, R. P., Lazenby, A., Birkenmeier, E. H., Sundberg, J. P., & Elson, C. O. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.855 · Cited by 383
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease
McGovern, D. P. B., Jones, M. R., Taylor, K. D., Marciante, K., Yan, X., Dubinsky, M., Ippoliti, A., Vasiliauskas, E., Berel, D., Derkowski, C., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq248 · Cited by 379
Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
Shanahan, F. (2001) · Gastroenterology · doi:10.1053/gast.2001.22122 · Cited by 371
Biologic therapy of inflammatory bowel disease
Sandborn, W. J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.33426 · Cited by 344
Oral Tolerance: Mechanisms and Therapeutic Applications
Faria, A. M. C., & Weiner, H. L. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60787-7 · Cited by 311
The host–microbe interface within the gut
Shanahan, F. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0342 · Cited by 299
Exposure to schistosome eggs protects mice from TNBS-induced colitis
Elliott, D. E., Li, J., Blum, A., Metwali, A., Qadir, K., Urban, J. F., & Weinstock, J. V. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00049.2002 · Cited by 288
Schmidt, C., Giese, T., Ludwig, B., Mueller-Molaian, I., Marth, T., Zeuzem, S., Meuer, S. C., & Stallmach, A. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00003 · Cited by 280
A Key Role of Dendritic Cells in Probiotic Functionality
Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., Sirard, J.-C., Pot, B., & Grangette, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000313 · Cited by 279
Mitochondrial dysfunction in inflammatory bowel disease
Novak, E. A., & Mollen, K. P. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00062 · Cited by 259
Duchmann, R., May, E., Heike, M., Knolle, P., Neurath, M., & zum Büschenfelde, K.-H. M. (1999) · Gut · doi:10.1136/gut.44.6.812 · Cited by 259
Self-citationTh1-type responses mediate spontaneous ileitis in a novel murine model of Crohn’s disease
Kosiewicz, M. M., Nast, C. C., Krishnan, A., Rivera-Nieves, J., Moskaluk, C. A., Matsumoto, S., Kozaiwa, K., & Cominelli, F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10956 · Cited by 248
Inflammatory bowel disease: past, present, and future
Sands, B. E. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1995-7 · Cited by 240
Waidmann, M., Bechtold, O., Frick, J.-S., Lehr, H.-A., Schubert, S., Dobrindt, U., Loeffler, J., Bohn, E., & Autenrieth, I. B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00672-3 · Cited by 234
Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation
Riedel, C. U. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i23.3729 · Cited by 210
Probiotics and Inflammatory Bowel Disease: Is There a Scientific Rationale?
Shanahan, F. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200005000-00007 · Cited by 201
Schultz, M., Tonkonogy, S. L., Sellon, R. K., Veltkamp, C., Godfrey, V. L., Kwon, J., Grenther, W. B., Balish, E., Horak, I., & Sartor, R. B. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.6.g1461 · Cited by 200
Wu, H.-Y., & Russell, M. W. (1997) · Immunologic Research · doi:10.1007/bf02786362 · Cited by 184
Inflammatory Bowel Disease: Autoimmune or Immune‐mediated Pathogenesis?
Wen, Z., & Fiocchi, C. (2004) · Journal of Immunology Research · doi:10.1080/17402520400004201 · Cited by 158
“Similar findings were seen in a hapten-induced model of experimental IBD (Duchmann et al., 1996).”
MATSUMOTO, S., NAGAOKA, M., HARA, T., KIMURA-TAKAGI, I., MISTUYAMA, K., & UEYAMA, S. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02462.x · Cited by 113
CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice
Nancey, S., Holvöet, S., Graber, I., Joubert, G., Philippe, D., Martin, S., Nicolas, J., Desreumaux, P., Flourié, B., & Kaiserlian, D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.018 · Cited by 112
Tight Mucosal Compartmentation of the Murine Immune Response to Antigens of the Enteric Microbiota
Konrad, A., Cong, Y., Duck, W., Borlaza, R., & Elson, C. O. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.055 · Cited by 94
Haller, D., Holt, L., Parlesak, A., Zanga, J., Bäuerlein, A., Sartor, R. B., & Jobin, C. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01874.x · Cited by 54
Metadata
- Authors
- Duchmann, R., Schmitt, E., Knolle, P., Zum Büschenfelde, K. M., & Neurath, M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1996-04
- Volume
- 26
- Issue
- 4
- Pages
- 934-938
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2159549010
- Cited by
- 345
- References
- 23
- FWCI
- 13.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.